The LDN Research Trust is proud to offer presentations introducing virtually all a practitioner would need to know about the effective use of LDN. For more extensive information on the use of LDN, be sure to register for a Full Ticket or Livestream so that you can also access our additional recorded sessions.
The research is pouring in fast about how diet and lifestyle can impact gut health, and how gut health affects all health.This presentation will share the latest studies that can help guide practical strategies, such as new findings about foods, supplements, various forms of fasting, and other habits.As always, Jill will focus on how patients can make the most progress with the least amount of deprivation and willpower, so that new healthy habits are maintainable long-term
Hypothyroidism is well understood in conventional medicine as an elevated TSH along with associated symptoms. Unfortunately, TSH is determine by the levels of T3 in the pituitary as determined by the type 2 deiodinase. In the periphery, type 1 deiodinase is what converts T4 into T3 while type 3 deiodinase converts T4 into reverse T3. Understanding what might cause a decrease in either type 1 or type 2 or an increase in type 3 deiodinase coupled with low dose naltrexone treatment could greatly improve lab and symptom outcomes in patients with hypothyroidism or for those who experience classical hypothyroid symptoms but have a TSH within range on a lab report.
There is much more to compounding pharmacy than mixing ingredients. This presentation will give a glimpse into the world of compounding pharmacy, the regulations and guidelines that we strive to meet, how to choose a compounding pharmacy, and how to writefor a low dose naltrexone compounded prescription. Specifically, different bases and equipment used in the compounding of low dose naltrexone will be discussed and how to choose the right dosage form for your unique patient.
Many general practitioners may feel intimidated to include LDN into their regular patient care.Dr. Mageruswill present 6 cases from her practice where she has successfully used LDN as an adjunctive therapy to treat infertility, lupus, endometriosis, multiple sclerosis and hashimoto's thyroiditis.
Mast cells are present in most tissues throughout the human body, especially connective tissue, skin, intestinal lining cardiovascular system, nervous system, and reproductive organs. They are part of the allergic response designed to protect us from threat and injury.When the body is exposed to a perceived threat, the mast cells secrete chemical mediators, such as histamine,interleukins, prostaglandins, cytokines, chemokine and various other chemicalsstored in the cytoplasm of the cell. These chemicalmessengers produce both local and systemic effects, such as increased permeability of blood vessels (inflammation and swelling), contraction of smooth muscle (stomach cramps and heart palpitations), and increase mucous production (congestion, sneezing, etc). Historically, we thought of mast cells only in relation to an allergic or anaphylactic response. We now know they play a profound role in immune activation, development of autoimmunity and many other disorders, such as POTS (postural orthostatic tachycardia syndrome). Sadly we are seeing a large increase in patients presenting with mast cell disorders and MCAS. I believe it is in part dueto the onslaught of more pervasiveenvironmental toxins, molds and chemicals.
This session will review the interactions and assessments in a community pharmacy practice that result in recommendations for LDN therapy initiation. The session will also review complementary therapies for patients seeking functional improvement of immune dysregulation
SIBO, small intestine bacterial overgrowth, is estimated to account for up to 60% of all IBS patients. That’s millions of patients. The core etiology of developing SIBO is due to auto-immune damage to the nerves that stimulate the muscles of the small gut to move contents forward. As a result, the colon backwashes bacteria/archae into the small gut and they proliferate, causing significant symptoms and damage to the small gut lining. Low Dose Naltrexone can be an invaluable tool in working with SIBO patients. It can help reduce the auto-immunity and acts as a gentle prokinetic, helping to move contents forward to prevent SIBO recurrence. Learn about SIBO, auto-immunity, prokinetics at this interesting lecture by a SIBO expert."
This talk with focus on two common connective tissue diseases, Sjogren's Syndromeand Systemic Lupus. There will be a review of both diseases in terms of diagnosis and treatment. In addition, informative case reports will be presented where LDN has been beneficial after standard therapy was not useful. In addition, there will be a brief discussion of why LDN may be an effective treatmentfor both controlling inflammation and disease symptoms.